Ensysce Biosciences Inc (ENSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Operating Expenses | 3,329 | 959 | 0 | 0 | 0 |
| Operating Income | -3,329 | -959 | N/A | N/A | N/A |
| Other Income | 2,817 | 3,635 | 0 | 0 | 0 |
| Pre-tax Income | -512 | 2,676 | 0 | 0 | 0 |
| Income Tax | 555 | 554 | N/A | N/A | N/A |
| Net Income Continuous | -1,067 | 2,122 | N/A | N/A | N/A |
| Net Income | $-1,067 | $2,122 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -2,267.77 | -791.92 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -631.68 | 1,272.46 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -2,267.77 | -791.92 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -631.68 | 1,272.46 | N/A | N/A | N/A |
| EBITDA(a) | $-3,329 | $-959 | $N/A | $N/A | $N/A |